Dr. Kurian is a Professor of Medicine and of Epidemiology and Population Health at Stanford University. She received her MD from Harvard Medical School and completed residency in Internal Medicine at Massachusetts General Hospital, after which she completed Oncology Fellowship and her MSc in Epidemiology at Stanford University School of Medicine. Dr. Kurian aims to improve breast and gynecologic cancer outcomes through research on the genetic epidemiology, prevention, and treatment of these cancers. Her work has contributed significantly to understanding inherited breast cancer risk, with a focus on cancer genetics in racially diverse populations. She has led studies to inform decision-making about managing cancer risks, including a simulation analysis of women with BRCA1 and BRCA2 mutations that culminated in a widely used clinical decision tool. Dr. Kurian leads a large, R01-funded study of genetic testing results linked to cancer registry data, studying the treatment and outcomes of women’s cancers at the population level. She has published more than 200 peer-reviewed articles and her work is funded by the National Institutes of Health and multiple foundations. As Director of the Stanford Women’s Clinical Cancer Genetics Program, Dr. Kurian maintains an active clinical practice caring for women diagnosed with, and at high risk for, breast and gynecologic cancers. She also serves on the National Comprehensive Cancer Network Panels for Genetic Risk of Breast/Ovarian Cancer and Breast Cancer Risk Reduction, developing evidence-based practice guidelines.